Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +26.1% | +4.2% | 2 / 3 | +15.1% | +2.51 pp | +1.91 pp | +24.1% | 0.00 | 12.18 | 1.363 | +15,1% | 299 | +26,1% | 12.18 | 14.74 | −17,3% |
| Pts | 4 | 0 | 8 | 8 | 8 | 8 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 89.800 (close price on 2026-10-19)EPS (TTM): 7.370
Financial charts
1.Revenue & growth
VND bn1.363Q2/26
1.Revenue & growth
VND bn1.363Q2/26
2.Profit & growth
VND bn299Q2/26
3.Profit mix (Penman)
VND bn1.127Q2/26
4.Margins & cost structure
%48.8%Q2/26
5.Returns & cash cycle
% · days45.1%Q2/26
6.Earnings quality & cash
VND bn713Q2/26
7.Asset structure
VND bn5.005Q2/26
8.Funding & debt health
VND bn · times5.005Q2/26
9.Revenue backlog
VND bn76,5Q2/26
10.Valuation
times · %12,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.284Q2/26
Adjusted EPS growth, latest quarter
26.1%
Average adjusted EPS growth, 3 quarters
4.2%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26